ZA887409B - Crystalline beta-lactam hydrate - Google Patents

Crystalline beta-lactam hydrate

Info

Publication number
ZA887409B
ZA887409B ZA887409A ZA887409A ZA887409B ZA 887409 B ZA887409 B ZA 887409B ZA 887409 A ZA887409 A ZA 887409A ZA 887409 A ZA887409 A ZA 887409A ZA 887409 B ZA887409 B ZA 887409B
Authority
ZA
South Africa
Prior art keywords
lactam
hydrate
crystalline beta
beta
crystalline
Prior art date
Application number
ZA887409A
Other languages
English (en)
Inventor
Carol Elaine Pasini
Elaine Pasini Carol
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA887409B publication Critical patent/ZA887409B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D463/00Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16Nitrogen atoms
    • C07D463/18Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA887409A 1987-10-06 1988-10-03 Crystalline beta-lactam hydrate ZA887409B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10576687A 1987-10-06 1987-10-06

Publications (1)

Publication Number Publication Date
ZA887409B true ZA887409B (en) 1990-06-27

Family

ID=22307671

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA887409A ZA887409B (en) 1987-10-06 1988-10-03 Crystalline beta-lactam hydrate

Country Status (32)

Country Link
EP (1) EP0311366B1 (ko)
JP (1) JP2641745B2 (ko)
KR (1) KR970002637B1 (ko)
CN (1) CN1029966C (ko)
AR (1) AR248407A1 (ko)
AT (1) ATE103916T1 (ko)
AU (1) AU598155B2 (ko)
BG (1) BG47036A3 (ko)
CA (1) CA1334970C (ko)
CS (1) CS270594B2 (ko)
DD (1) DD273634A5 (ko)
DE (1) DE3888913T2 (ko)
DK (1) DK170070B1 (ko)
EG (1) EG18529A (ko)
ES (1) ES2063049T3 (ko)
FI (1) FI884554A (ko)
HK (1) HK15497A (ko)
HU (1) HU206348B (ko)
IE (1) IE62108B1 (ko)
IL (1) IL87905A (ko)
MX (1) MX13277A (ko)
MY (1) MY104063A (ko)
NO (1) NO884416L (ko)
NZ (1) NZ226450A (ko)
OA (1) OA08958A (ko)
PH (1) PH31002A (ko)
PL (1) PL152022B1 (ko)
PT (1) PT88662B (ko)
SU (1) SU1731058A3 (ko)
UA (1) UA19149A (ko)
YU (1) YU46699B (ko)
ZA (1) ZA887409B (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY103554A (en) * 1987-10-07 1993-07-31 Lilly Co Eli Manohydrate and solvates of a new (beta)-lactam antibiotic.
CA2002596A1 (en) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates of b-lactam antibiotic
CA2002597C (en) * 1988-11-14 1999-03-23 Thomas M. Eckrich Solvates of b-lactam antibiotic
CA2034592C (en) * 1990-01-26 2001-06-05 Ralph R. Pfeiffer Crystalline hydrochloride of new beta-lactam antibiotic and process therefor
US5374719A (en) * 1993-06-04 1994-12-20 Eli Lilly And Company Process for converting loracarbef dihydrate to loracarbef monohydrate
US5352782A (en) * 1993-06-04 1994-10-04 Eli Lilly And Company Process for preparing crystalline β-lactam monohydrate
US5399686A (en) * 1993-06-04 1995-03-21 Eli Lilly And Company Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate
US5550231A (en) * 1993-06-15 1996-08-27 Eli Lilly And Company Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
US5412094A (en) * 1993-06-28 1995-05-02 Eli Lilly And Company Bicyclic beta-lactam/paraben complexes
US5580977A (en) * 1995-03-01 1996-12-03 Eli Lilly And Company Process for preparing loracarbef monohydrate
US6001996A (en) * 1995-05-11 1999-12-14 Eli Lilly And Company Complexes of cephalosporins and carbacephalosporins with parabens
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
ES2318274T3 (es) 2003-03-07 2009-05-01 Schering Corporation Compuestos de azetidinona sustituida, formulaciones y uso de los mismos para el tratamiento de hipercolesterolemia.
JP5137228B2 (ja) 2003-03-07 2013-02-06 メルク・シャープ・アンド・ドーム・コーポレーション 高コレステロール血症の処置のための置換アゼチジノン化合物、置換アゼチジノン処方物およびそれらの使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3655656A (en) * 1970-06-04 1972-04-11 Lilly Co Eli Crystalline cephalexin monohydrate
JPS5672698A (en) * 1979-11-14 1981-06-16 Kyowa Hakko Kogyo Co Ltd Preparation of optically active cephalosporin analogue
MY103554A (en) * 1987-10-07 1993-07-31 Lilly Co Eli Manohydrate and solvates of a new (beta)-lactam antibiotic.

Also Published As

Publication number Publication date
JP2641745B2 (ja) 1997-08-20
EG18529A (en) 1993-04-30
EP0311366B1 (en) 1994-04-06
KR890006644A (ko) 1989-06-15
YU46699B (sh) 1994-04-05
MY104063A (en) 1993-11-30
IE62108B1 (en) 1994-12-14
DK553788D0 (da) 1988-10-04
CA1334970C (en) 1995-03-28
IL87905A (en) 1992-06-21
PH31002A (en) 1997-12-23
NO884416D0 (no) 1988-10-05
DE3888913T2 (de) 1994-08-11
DE3888913D1 (de) 1994-05-11
NZ226450A (en) 1990-05-28
DD273634A5 (de) 1989-11-22
YU184588A (en) 1990-02-28
IL87905A0 (en) 1989-03-31
HUT48884A (en) 1989-07-28
NO884416L (no) 1989-04-07
FI884554A0 (fi) 1988-10-04
KR970002637B1 (ko) 1997-03-07
OA08958A (en) 1990-11-30
AR248407A1 (es) 1995-08-18
AU598155B2 (en) 1990-06-14
CN1032793A (zh) 1989-05-10
HK15497A (en) 1997-02-14
IE883015L (en) 1989-04-06
ATE103916T1 (de) 1994-04-15
UA19149A (uk) 1997-12-25
HU206348B (en) 1992-10-28
JPH01128983A (ja) 1989-05-22
ES2063049T3 (es) 1995-01-01
EP0311366A1 (en) 1989-04-12
DK170070B1 (da) 1995-05-15
PL152022B1 (en) 1990-10-31
CS666688A2 (en) 1989-11-14
BG47036A3 (en) 1990-04-16
PL275093A1 (en) 1989-05-02
FI884554A (fi) 1989-04-07
PT88662A (pt) 1988-11-01
AU2337288A (en) 1989-04-06
CN1029966C (zh) 1995-10-11
MX13277A (es) 1993-11-01
DK553788A (da) 1989-04-07
CS270594B2 (en) 1990-07-12
PT88662B (pt) 1992-12-31
SU1731058A3 (ru) 1992-04-30

Similar Documents

Publication Publication Date Title
AR243893A1 (es) Un procedimiento para preparar un hidrato cristalino del acido 7 beta-((z)) 2-(2-aminotiazol-4-il)-4-carboxibut-2-enoilamino)-3-cefem-4-carboxil ico
SG28378G (en) Highly crystalline polypropylene
JPS6461455A (en) Compound
JPS6450878A (en) Sulfonamidothienylcarboxylic compound
JPS6485964A (en) Compound
HK15497A (en) Crystalline beta-lactam hydrate
EP0277033A3 (en) Vapochromic double-complex salts
IL89150A0 (en) Crystalline beta-lactam solvate
GB8711830D0 (en) Mouth bit
ZA873010B (en) Crystalline hydrate
IL80474A0 (en) Crystalline cephalosporin monohydrate
ZA884414B (en) Benzodipyran compound
GB8701378D0 (en) Crystalline compound
IE872121L (en) Substituted hydroxypropylamine derivatives
GB8726180D0 (en) Cephem compounds
GB8705497D0 (en) Cephem compounds
GB8722358D0 (en) Compound
GB8709804D0 (en) Crystalline cefadroxil
KR890006270Y1 (en) Defent for lock
IE871408L (en) Cephalosporin compounds
IE871300L (en) Cephalosporin compounds
AU98692S (en) Bit holder
GB8708521D0 (en) 7-(-hydroxyiminocarboxylic acylamino)-3-cephem compounds
IE871111L (en) Crystalline penemcarboxylic acid mono hydrate
CS69487A1 (en) Zapojeni hydraulickych prvku pro nesoucasny chod hydromotoru